{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:30:45Z","timestamp":1771529445815,"version":"3.50.1"},"reference-count":22,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Small dense LDL cholesterol is a strong risk factor for atherosclerosis. However, few studies have investigated the impacts of this specific lipid profile on the incident risk of adverse cardiovascular events in patients with acute coronary syndrome. Materials and Methods: Patients with acute coronary syndrome, who underwent revascularization, were included and followed for 2 years. The levels of small dense LDL cholesterol were measured at index discharge (day 0) in the setting of newly administered therapies for secondary prevention, including aspirin and statins, during the index hospitalization. The prognostic impact of small dense LDL-cholesterol levels on the risk of a primary composite endpoint, including cardiac death, non-fatal myocardial infarction, unstable angina pectoris, stroke, and heart failure, was investigated. Results: In total, 46 patients (median 75 (59, 83) years old, 63% men) were included. Median small dense LDL cholesterol was 19.4 (13.5, 23.8) mg\/dL at index discharge. All patients initiated statin treatment before the index discharge, with a median LDL-cholesterol level of 77 (64, 109) mg\/dL. Small dense LDL-cholesterol level was independently associated with an incremental risk for the primary endpoint (p &lt; 0.05 by adjusting for several potential risk factors, including LDL cholesterol) with a cutoff of 32.6 mg\/dL. Conclusions: Small dense LDL-cholesterol level was a significant risk factor for cardiovascular events following presentations of acute coronary syndrome.<\/jats:p>","DOI":"10.3390\/medicina59010158","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T02:05:52Z","timestamp":1673575552000},"page":"158","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic Implication of Small Dense LDL-Cholesterol Levels following Acute Coronary Syndrome"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7294-7637","authenticated-orcid":false,"given":"Teruhiko","family":"Imamura","sequence":"first","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Hori","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Narang","sequence":"additional","affiliation":[{"name":"Advocate Christ Medical Center, Oak Lawn, IL 60453, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9747-2511","authenticated-orcid":false,"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1273042","DOI":"10.1155\/2017\/1273042","article-title":"Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases","volume":"2017","author":"Ivanova","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Vekic, J., Zeljkovic, A., Cicero, A.F.G., Janez, A., Stoian, A.P., Sonmez, A., and Rizzo, M. (2022). Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL. Medicina, 58.","DOI":"10.3390\/medicina58020299"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12944-017-0417-6","article-title":"Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels","volume":"16","author":"Hayashi","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5551\/jat.RV17023","article-title":"Pathophysiology of Diabetic Dyslipidemia","volume":"25","author":"Hirano","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: The Atherosclerosis Risk In Communities (ARIC) study","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacc.2012.11.009","article-title":"Remnant cholesterol: \u201cNon-(HDL-C + LDL-C)\u201d as a coronary artery disease risk factor","volume":"61","author":"McPherson","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.ATV.0000154144.73236.f4","article-title":"Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study","volume":"25","author":"Cantin","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5551\/jat.51961","article-title":"Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community","volume":"27","author":"Higashioka","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.5551\/jat.49841","article-title":"High sdLDL Cholesterol can be Used to Reclassify Individuals with Low Cardiovascular Risk for Early Intervention: Findings from the Chinese Multi-Provincial Cohort Study","volume":"27","author":"Qi","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.atherosclerosis.2014.01.034","article-title":"Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease","volume":"233","author":"Williams","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12933-020-01015-6","article-title":"Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: A prospective, observational cohort study","volume":"19","author":"Jin","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/ggi.13287","article-title":"Small dense low-density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease","volume":"18","author":"Sakai","year":"2018","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.5551\/jat.60152","article-title":"Small Dense Low-Density Lipoprotein Cholesterol: A Residual Risk for Rapid Progression of Non-Culprit Coronary Lesion in Patients with Acute Coronary Syndrome","volume":"28","author":"Sekimoto","year":"2021","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhang, J., and He, L. (2021). Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. BMC Cardiovasc. Disord., 21.","DOI":"10.1186\/s12872-021-01979-7"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5551\/jat.14936","article-title":"Small dense low-density lipoproteins cholesterol can predict incident cardiovascular disease in an urban Japanese cohort: The Suita study","volume":"20","author":"Arai","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.pcad.2020.04.009","article-title":"Small dense low-density lipoprotein-cholesterol (sdLDL-C): Analysis, effects on cardiovascular endpoints and dietary strategies","volume":"63","author":"Santos","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5551\/jat.10.186","article-title":"Assessment of LDL particle size by triglyceride\/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia","volume":"10","author":"Maruyama","year":"2003","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e019140","DOI":"10.1161\/JAHA.120.019140","article-title":"Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study","volume":"10","author":"Ikezaki","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.5551\/jat.54130","article-title":"Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression","volume":"27","author":"Ikezaki","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11883-020-0823-5","article-title":"Pemafibrate, a New Selective PPARalpha Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases","volume":"22","author":"Yamashita","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ahj.2018.09.011","article-title":"Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study","volume":"206","author":"Pradhan","year":"2018","journal-title":"Am. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.metabol.2014.08.010","article-title":"Diabetic dyslipidemia","volume":"63","author":"Wu","year":"2014","journal-title":"Metabolism"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/158\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:04:46Z","timestamp":1760119486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["medicina59010158"],"URL":"https:\/\/doi.org\/10.3390\/medicina59010158","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]}}}